Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 226

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 4
Chunk 226
---
 at an exercise price of $6.382
per share; and (iv) 22,554 shares of our common stock issuable upon exercise of the February 2025 Placement Agent Warrants at an exercise
price of $4.469 per share.

(B) Use of Proceeds

None.

(C) Issuer Purchases of Equity Securities

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not Applicable.

38

ITEM 5. OTHER INFORMATION

Securities Trading Plans

During the three months ended March 31, 2025,
none of our Section 16 officers or directors (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated any contract, instruction
or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)
of the Exchange Act or any “non-Rule 10b5-1 trading arrangement” (as defined in Section 408(c) of Regulation S-K).

ITEM 6. EXHIBITS

EXHIBIT INDEX

    Exhibit No.
     
    Description
  
    1.1
     
    Engagement Agreement (incorporated by reference to
    Exhibit 1.1 of the Company’s Current Report on Form 8-K filed on January 30, 2025)
  
    1.2
     
    Amendment to Engagement Agreement (incorporated by
    reference to Exhibit 1.2 of the Company’s Current Report on Form 8-K filed on January 30, 2025)
  
    1.3
     
    Extension to Engagement Agreement (incorporated by
    reference to Exhibit 1.3 of the Company’s Current Report on Form 8-K filed on January 30, 2025)
  
    4.1
     
    Form of Warrant (incorporated by reference to Exhibit
    4.1 of the Company’s Current Report on Form 8-K filed on January 30, 2025)
  
    4.2
     
    Form of Placement Agent Warrant (incorporated by reference
    to Exhibit 4.2 of the Company’s Current Report on Form 8-K filed on January 30, 2025)
  
    4.3
     
    Form of W